Nuclear Magnetic Resonance Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells

BACKGROUND: Malignant gliomas are rapidly growing tumours that extensively invade the brain and have bad prognosis. Our study was performed to assess the metabolic effects of bevacizumab on the glioma cells carrying the IDH1 mutation, a mutation, associated with better prognosis and treatment outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesti, Tanja, Bouchemal, Nadia, Banissi, Claire, Triba, Mohamed N., Marbeuf-Gueye, Carole, Cemazar, Maja, Moyec, Laurence Le, Carpentier, Antoine F., Savarin, Philippe, Ocvirk, Janja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287186/
https://www.ncbi.nlm.nih.gov/pubmed/30511933
http://dx.doi.org/10.2478/raon-2018-0046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287186/
https://www.ncbi.nlm.nih.gov/pubmed/30511933
http://dx.doi.org/10.2478/raon-2018-0046

Ejemplares similares